People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic ...

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

The VET PFAS Act could help older veterans with toxic exposure attain the medical treatment they need by expanding ...

This year’s most-viewed articles and videos on myelodysplastic syndromes (MDS) explored patient quality of life, risk factors ...

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Tiago Biachi, MD, PhD, discusses the challenges of treating gastrointestinal (GI) cancers, particularly the limited effectiveness of immunotherapy for "cold tumors" and the need to make them more ...

Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with ...